Evidence map›Paper›PMID 37277372›Full record

ArticleNPJ Parkinson's disease2023

Distinct cortical and subcortical predictors of Purdue Pegboard decline in Parkinson's disease and atypical parkinsonism.

Bradley J Wilkes, Emily R Tobin, David J Arpin, Wei-En Wang, Michael S Okun, Michael S Jaffee, Nikolaus R McFarland, Daniel M Corcos, David E Vaillancourt

Open access · goldAbstract read
In one paragraph

Article in NPJ Parkinson's disease, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
3.5field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Bradley J WilkesDepartment of Applied Physiology and Kinesiology, University of Florida, Gainesville, FL, USA. bwilkes@ufl.edu.ORCID http://orcid.org/0000-0003-0477-3505
Emily R TobinDepartment of Applied Physiology and Kinesiology, University of Florida, Gainesville, FL, USA.ORCID http://orcid.org/0000-0002-4405-7207
David J ArpinDepartment of Applied Physiology and Kinesiology, University of Florida, Gainesville, FL, USA.ORCID http://orcid.org/0000-0002-6442-1205
Wei-En WangDepartment of Applied Physiology and Kinesiology, University of Florida, Gainesville, FL, USA.
Michael S OkunDepartment of Neurology, Norman Fixel Institute for Neurological Diseases, University of Florida, Gainesville, FL, USA.ORCID http://orcid.org/0000-0002-6247-9358
Michael S JaffeeDepartment of Neurology, Norman Fixel Institute for Neurological Diseases, University of Florida, Gainesville, FL, USA.
Nikolaus R McFarlandDepartment of Neurology, Norman Fixel Institute for Neurological Diseases, University of Florida, Gainesville, FL, USA.ORCID http://orcid.org/0000-0002-8699-8857
Daniel M CorcosDepartment of Physical Therapy and Human Movement Sciences, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.
David E VaillancourtDepartment of Applied Physiology and Kinesiology, University of Florida, Gainesville, FL, USA.
University of Florida · USNorthwestern University · US

Funding

Neuroimaging Biomarkers in Parkinsonism: Differentiating Subtypes and Tracking Disease ProgressionU01NS102038 · NINDS · UNIVERSITY OF FLORIDA · PI CORCOS, DANIEL M., VAILLANCOURT, DAVID E · 2017 to 2019
$2.3M
Advanced 3T for Structural and Functional Imaging at University of FloridaS10OD021726 · OD · UNIVERSITY OF FLORIDA · PI LONG, JOANNA R · 2017 to 2017
$2.0M
NIH HHS S10 OD021726U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke (NINDS) U01NS102038
6 · The paper itself

Abstract

Objective measures of disease progression are critically needed in research on Parkinson's disease (PD) and atypical Parkinsonism but may be hindered by both practicality and cost. The Purdue Pegboard Test (PPT) is objective, has high test-retest reliability, and has a low cost. The goals of this study were to determine: (1) longitudinal changes in PPT in a multisite cohort of patients with PD, atypical Parkinsonism, and healthy controls; (2) whether PPT performance reflects brain pathology revealed by neuroimaging; (3) quantify kinematic deficits shown by PD patients during PPT. Parkinsonian patients showed a decline in PPT performance that correlated with motor symptom progression, which was not seen in controls. Neuroimaging measures from basal ganglia were significant predictors of PPT performance in PD, whereas cortical, basal ganglia, and cerebellar regions were predictors for atypical Parkinsonism. Accelerometry in a subset of PD patients showed a diminished range of acceleration and irregular patterns of acceleration, which correlated with PPT scores.

Identifiers

PMID37277372
PMCPMC10241903
OpenAlexW4379468003

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.